Boris V. Afanasyev

Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer

M. R. Green, George Manikhas, Boris V. Afanasyev et al. · Annals of Oncology · 2006 · 647 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +13

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

Andrew H. Wei, Hartmut Döhner, Christopher Pocock et al. · New England Journal of Medicine · 2020 · 424 citations · Full text

Medicine, Oncology, Pharmacology +10

Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

Tapani Ruutu, Aloïs Gratwohl, T. de Witte et al. · Bone Marrow Transplantation · 2013 · 310 citations

Veterinary Medicine, Internal Medicine, Good Clinical Practice +4

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee et al. · The Lancet Infectious Diseases · 2019 · 254 citations · Full text

Veterinary Medicine, Immunology, Oncology +16

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)

Nicolaus Kröger, Simona Iacobelli, Georg‐Nikolaus Franke et al. · Journal of Clinical Oncology · 2017 · 249 citations · Full text

Medicine, Hematology, Immunology +15